Janney Montgomery Scott LLC acquired a new stake in Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,470 shares of the technology company's stock, valued at approximately $338,000. Janney Montgomery Scott LLC owned approximately 0.19% of Kewaunee Scientific at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the stock. De Lisle Partners LLP boosted its stake in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock valued at $1,446,000 after acquiring an additional 11,511 shares in the last quarter. Geode Capital Management LLC boosted its stake in Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after acquiring an additional 1,941 shares in the last quarter. Ritholtz Wealth Management boosted its stake in Kewaunee Scientific by 15.6% in the fourth quarter. Ritholtz Wealth Management now owns 12,619 shares of the technology company's stock valued at $781,000 after acquiring an additional 1,706 shares in the last quarter. State Street Corp acquired a new position in Kewaunee Scientific in the third quarter valued at $266,000. Finally, Barclays PLC acquired a new position in Kewaunee Scientific in the third quarter valued at $121,000. Institutional investors and hedge funds own 32.69% of the company's stock.
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, December 18th.
View Our Latest Stock Analysis on KEQU
Insider Transactions at Kewaunee Scientific
In related news, VP Elizabeth D. Phillips sold 1,850 shares of the stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total transaction of $100,214.50. Following the completion of the transaction, the vice president now directly owns 13,591 shares of the company's stock, valued at $736,224.47. This represents a 11.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Donald T. Gardner III sold 1,257 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now directly owns 21,358 shares of the company's stock, valued at $1,265,675.08. This represents a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 11,994 shares of company stock worth $729,430. Company insiders own 14.20% of the company's stock.
Kewaunee Scientific Stock Performance
Shares of KEQU traded down $3.60 during mid-day trading on Friday, hitting $66.07. 20,334 shares of the company's stock were exchanged, compared to its average volume of 24,471. Kewaunee Scientific Co. has a fifty-two week low of $27.00 and a fifty-two week high of $71.33. The firm has a market capitalization of $189.62 million, a P/E ratio of 10.47 and a beta of 0.71. The business's 50 day moving average is $59.24 and its two-hundred day moving average is $47.42. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, December 11th. The technology company reported $1.41 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
About Kewaunee Scientific
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Stories
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
